449 related articles for article (PubMed ID: 32547029)
1. Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases.
Passi M; Shahid S; Chockalingam S; Sundar IK; Packirisamy G
Int J Nanomedicine; 2020; 15():3803-3826. PubMed ID: 32547029
[TBL] [Abstract][Full Text] [Related]
2. Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.
Vij N
Expert Opin Drug Deliv; 2011 Sep; 8(9):1105-9. PubMed ID: 21711085
[TBL] [Abstract][Full Text] [Related]
3. Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.
Xu Y; Liu H; Song L
J Nanobiotechnology; 2020 Oct; 18(1):145. PubMed ID: 33076918
[TBL] [Abstract][Full Text] [Related]
4. Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic obstructive pulmonary disease.
Jin Z; Pan X; Zhou K; Bi H; Wang L; Yu L; Wang Q
J Int Med Res; 2015 Jun; 43(3):303-10. PubMed ID: 25834280
[TBL] [Abstract][Full Text] [Related]
5. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD).
Psarras S; Caramori G; Contoli M; Papadopoulos N; Papi A
Curr Pharm Des; 2005; 11(16):2053-62. PubMed ID: 15974958
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.
Liu Z; Geng W; Jiang C; Zhao S; Liu Y; Zhang Y; Qin S; Li C; Zhang X; Si Y
Exp Biol Med (Maywood); 2017 Sep; 242(15):1534-1541. PubMed ID: 28795606
[TBL] [Abstract][Full Text] [Related]
8. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.
Ito K; Colley T; Mercado N
Int J Chron Obstruct Pulmon Dis; 2012; 7():641-52. PubMed ID: 23055713
[TBL] [Abstract][Full Text] [Related]
9. Nanocarrier-based approaches to combat chronic obstructive pulmonary disease.
Virmani T; Kumar G; Virmani R; Sharma A; Pathak K
Nanomedicine (Lond); 2022 Oct; 17(24):1833-1854. PubMed ID: 35856251
[TBL] [Abstract][Full Text] [Related]
10. Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease.
Easter M; Bollenbecker S; Barnes JW; Krick S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967225
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of Airway-Targeted PLGA-PEG Nanoparticles for Drug Delivery in Obstructive Lung Diseases.
Vij N
Methods Mol Biol; 2020; 2118():147-154. PubMed ID: 32152977
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
Yoshida T; Tuder RM
Physiol Rev; 2007 Jul; 87(3):1047-82. PubMed ID: 17615396
[TBL] [Abstract][Full Text] [Related]
13. [Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].
Wang S; Xiong L; Deng X; Ren W; Zhu C; Li C; Zhou Q
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(22):1726-30. PubMed ID: 26704155
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis in chronic obstructive pulmonary disease and therapeutic potential by targeting AMP-activated protein kinase.
Zhang Z; Cheng X; Yue L; Cui W; Zhou W; Gao J; Yao H
J Cell Physiol; 2018 Mar; 233(3):1999-2006. PubMed ID: 28160496
[TBL] [Abstract][Full Text] [Related]
15. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
16. COPD: current therapeutic interventions and future approaches.
Barnes PJ; Stockley RA
Eur Respir J; 2005 Jun; 25(6):1084-106. PubMed ID: 15929966
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
Dijkstra AE; de Jong K; Boezen HM; Kromhout H; Vermeulen R; Groen HJ; Postma DS; Vonk JM
Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.
de Boer WI; Alagappan VK; Sharma HS
Cell Biochem Biophys; 2007; 47(1):131-48. PubMed ID: 17406066
[TBL] [Abstract][Full Text] [Related]
19. Preclinical murine models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Bozinovski S
Eur J Pharmacol; 2015 Jul; 759():265-71. PubMed ID: 25818750
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.
Hikichi M; Mizumura K; Maruoka S; Gon Y
J Thorac Dis; 2019 Oct; 11(Suppl 17):S2129-S2140. PubMed ID: 31737341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
